1. Home
  2. NEOG vs AMLX Comparison

NEOG vs AMLX Comparison

Compare NEOG & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$9.51

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$16.05

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
AMLX
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
NEOG
AMLX
Price
$9.51
$16.05
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$10.67
$21.56
AVG Volume (30 Days)
2.7M
1.1M
Earning Date
04-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.46
EPS
0.02
N/A
Revenue
$894,661,000.00
$380,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$466.25
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$4.53
$4.41
52 Week High
$11.43
$18.61

Technical Indicators

Market Signals
Indicator
NEOG
AMLX
Relative Strength Index (RSI) 50.98 48.78
Support Level $8.98 $12.29
Resistance Level $10.12 $17.22
Average True Range (ATR) 0.36 0.81
MACD 0.00 -0.26
Stochastic Oscillator 56.25 19.91

Price Performance

Historical Comparison
NEOG
AMLX

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: